glucagon-like peptide 1 and 2 receptor co-agonist (Gubra)

N/A

Report date: 2025/06/11 10:43:13
NME

Base Information

Drug Nameglucagon-like peptide 1 and 2 receptor co-agonist (Gubra)
Drug Alias NameGUB09-145GUB09-123
ClassificationSmall molecules
Mechanisms of ActionGlucagon-like peptide 1 receptor agonistsGlucagon-like peptide 2 receptor agonists
TargetsGlucagon-like peptide 2 receptorGlucagon-like peptide 1 receptor
Therapy Area/IndicationsDiabetes Mellitus
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryDenmark
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesGubra Aps
China Registration ClassN/A

Develop Information

Active CompaniesGubra Aps
Inactive CompaniesN/A
Active IndicationsDiabetes Mellitus
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A